Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival
- PMID: 21704331
- PMCID: PMC3154461
- DOI: 10.1016/j.jss.2011.04.061
Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival
Abstract
Background: Lung cancer is the second most common neoplasm and the leading cause of cancer deaths in the United States. In cancer, weight loss and obesity are associated with reduced survival. However, the effect of obesity or weight loss at presentation on lung cancer survival has not been well studied.
Materials and methods: Using an extensive cancer dataset, we identified 76,086 patients diagnosed with lung cancer during the period of 1998-2002, of which 14,751 patients presented with obesity and/or weight loss. We examined the relationship between survival and weight loss or obesity at diagnosis using univariate and multivariate analysis.
Results: Median survival time (MST) for all lung cancer patients was 8.7 mo. Patients presenting with weight loss (15.8%) had shorter MST versus those who did not (6.4 versus 9.2 mo, P < 0.001) and patients with weight loss had significantly shortened MST for all stages and histologic subtypes. In contrast, obese patients at presentation (5.4%) had longer MST relative to non-obese patients (13.0 versus 8.6 mo, P < 0.001), which was significant across all stages and histologic subtypes. Multivariate analysis revealed that the absence of weight loss was an independent, positive predictor of improved survival (HR = 0.087, P < 0.001), while the absence of obesity was an independent predictor of worsened survival in lung cancer (HR = 1.16, P < 0.001).
Conclusions: Our results demonstrate an inverse relationship between survival and weight loss at presentation and a potentially protective effect of obesity in lung cancer survival, which could be due to greater physiologic reserves, thereby prolonging life by slowing the progress of cancer cachexia.
Copyright © 2011 Elsevier Inc. All rights reserved.
Conflict of interest statement
None of the authors declares a conflict of interest.
Figures
Similar articles
-
Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.J Clin Oncol. 2013 Apr 20;31(12):1539-47. doi: 10.1200/JCO.2012.45.2722. Epub 2013 Mar 25. J Clin Oncol. 2013. PMID: 23530101
-
Post-diagnosis weight loss as a prognostic factor in non-small cell lung cancer.J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):86-92. doi: 10.1002/jcsm.12253. Epub 2017 Dec 4. J Cachexia Sarcopenia Muscle. 2018. PMID: 29205930 Free PMC article.
-
An analysis of the relationship between metastases and cachexia in lung cancer patients.Cancer Med. 2016 Sep;5(9):2641-8. doi: 10.1002/cam4.841. Epub 2016 Aug 3. Cancer Med. 2016. PMID: 27485414 Free PMC article.
-
Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC).Lung Cancer. 2017 Feb;104:52-57. doi: 10.1016/j.lungcan.2016.11.017. Epub 2016 Dec 1. Lung Cancer. 2017. PMID: 28213000
-
Time to progression as a surrogate marker for overall survival in patients with advanced non-small cell lung cancer.J Thorac Oncol. 2009 Mar;4(3):311-7. doi: 10.1097/JTO.0b013e3181989bd2. J Thorac Oncol. 2009. PMID: 19190515 Review.
Cited by
-
Exploring the association between asthma and chronic comorbidities: impact on clinical outcomes.Front Med (Lausanne). 2024 Jan 26;11:1305638. doi: 10.3389/fmed.2024.1305638. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38343638 Free PMC article. Review.
-
The impact of social determinants of health on textbook oncological outcomes and overall survival in locally advanced non-small cell lung cancer.JTCVS Open. 2023 Sep 19;16:888-906. doi: 10.1016/j.xjon.2023.09.013. eCollection 2023 Dec. JTCVS Open. 2023. PMID: 38204620 Free PMC article.
-
Obesity worsens mitochondrial quality control and does not protect against skeletal muscle wasting in murine cancer cachexia.J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):124-137. doi: 10.1002/jcsm.13391. Epub 2023 Dec 7. J Cachexia Sarcopenia Muscle. 2024. PMID: 38062911 Free PMC article.
-
A promising prognostic grading system incorporating weight loss and inflammation in patients with advanced cancer.J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2969-2980. doi: 10.1002/jcsm.13376. Epub 2023 Nov 20. J Cachexia Sarcopenia Muscle. 2023. PMID: 37985353 Free PMC article.
-
Male sex and pretreatment weight loss are associated with poor outcome in patients with advanced non-small cell lung cancer treated with immunotherapy: a retrospective study.Sci Rep. 2023 Oct 9;13(1):17047. doi: 10.1038/s41598-023-43866-5. Sci Rep. 2023. PMID: 37813923 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
-
- Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–1638. - PubMed
-
- Kollarova H, Machova L, Horakova D, Cizek L, Janoutova G, et al. Is obesity a preventive factor for lung cancer? Neoplasma. 2008;55:71–73. - PubMed
